Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...
S.BIOMEDICS has reported encouraging one-year post-transplant outcomes from a Phase I/IIa study of its cell therapy, TED-A9, for treating Parkinson's disease ... FP-CIT PET scans, which showed ...
Researchers from the Champalimaud Foundation have shed light on the puzzling relationship between dopamine and rest tremor in Parkinson's disease ... dopamine PET scans and MRI, to identify ...
More effective diagnostics are also being developed to monitor the progression of Parkinson’s disease in patients. The pharmaceutical company Merck has developed an alpha-synuclein PET ligand ...
DBS works miracle for young-onset patient of Parkinson's Parkinson's disease is a progressive disorder of the nervous system that affects body movement. It ...
Parkinson's disease is a progressive neurodegenerative disorder, which is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Motor symptoms are ...
Parkinson's disease (PD) is a common neurodegenerative disorder ... Sometimes, a dopamine transporter scan (DaTscan) is ordered which can help show a loss of dopamine in the deeper structures of the ...